lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer

Oncolytic vaccinia virus (OVV) has demonstrated appropriate safety profiles for clinical development. Although designed to kill cancer cells efficiently, OVV sensitivity varies in individual cancers, and predictive biomarkers of therapeutic responses have not been identified. Here we found that OVV...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Ther Oncolytics
Hlavní autoři: Horita, Kosuke, Kurosaki, Hajime, Nakatake, Motomu, Kuwano, Nozomi, Oishi, Tetsuro, Itamochi, Hiroaki, Sato, Sho, Kono, Hiromichi, Ito, Mai, Hasegawa, Kosei, Harada, Tasuku, Nakamura, Takafumi
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Gene & Cell Therapy 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463205/
https://ncbi.nlm.nih.gov/pubmed/31011626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.03.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky